Instructions for use Flekosteel

How to use Flekosteel instruction in Croatia

Gel for joints and spine

Method of administration and dosage

For adults and children over 12 years of age, the drug is applied in a thin layer on the inflamed area of the skin 2-3 times a day at a dose of 2 g (about 4 cm, a tube) and rub lightly. Single dose of the drug - 2 g The maximum daily dose should not exceed 6 g. Use the minimum effective doses for the minimum short course. Use Flekosteel with instructions only, method of use, and doses as specified in the instructions.

Testimonies	Contraindications
Posttraumatic inflammation of soft tissues, for example, due to stretching, overload, bruising, injuries; - Rheumatic diseases and soft tissue swelling (tendovaginitis, bursitis, periarticular tissue damage, wrist syndrome); - Pain in the joints (finger joints), elbows, etc. Sh. ) With osteoarthritis; - Back pain in inflammatory and degenerative diseases of the spine (osteoarthritis, sciatica, lumbago, sciatica). The drug is intended for symptomatic therapy, reducing pain and inflammation, affects the progression of the disease.	- Hypersensitivity to diclofenac or other components of the drug; - Complete or incomplete combination of bronchial asthma, recurrent polyposis of the nasal colon sinuses, intolerance to salicylates or other nonsteroidal anti-inflammatory drugs (including medical history); - Pregnancy (III trimester); - Breastfeeding period; - Age of children (up to 12 years); - Violation of the integrity of the skin at the destination of the application.

Testimonies

Contraindications

Posttraumatic inflammation of soft tissues, for example, due to stretching, overload, bruising, injuries; - Rheumatic diseases and soft tissue swelling (tendovaginitis, bursitis, periarticular tissue damage, wrist syndrome); - Pain in the joints (finger joints), elbows, etc. Sh. ) With osteoarthritis; - Back pain in inflammatory and degenerative diseases of the spine (osteoarthritis, sciatica, lumbago, sciatica). The drug is intended for symptomatic therapy, reducing pain and inflammation, affects the progression of the disease.

- Hypersensitivity to diclofenac or other components of the drug; - Complete or incomplete combination of bronchial asthma, recurrent polyposis of the nasal colon sinuses, intolerance to salicylates or other nonsteroidal anti-inflammatory drugs (including medical history); - Pregnancy (III trimester); - Breastfeeding period; - Age of children (up to 12 years); - Violation of the integrity of the skin at the destination of the application.